Published on
May 5, 2025
FDA Tries to Slam Shut the Revolving Door—After Decades of Industry Capture
From cozy relationships to blockbuster approvals, a new FDA policy promises transparency after decades of industry entanglement. But is it too little, too late? In a dramatic break from decades of cozy entanglement with Big Pharma, the US Food and Drug …
Source:
Freedom Magazine
-
Indeterminate
